David Wholley, Director, The Biomarkers Consortium
David Wholley manages The Biomarkers Consortium for the Foundation for the National Institutes of Health. He has also served as Director of the Genetic Association Information Network (GAIN), a public-private partnership dedicated to helping discover the genetic basis of common disease, and led the development of a major public-private partnership in drug safety with the biopharmaceutical industry and FDA. Prior to joining the Foundation in 2006 Mr. Wholley’s career spanned nearly 25 years in healthcare technology business management, including extensive experience in product development, sales, marketing, corporate strategy and partnership and project development. Mr. Wholley has held senior management roles in several venture-funded technology startup companies, including head of Global Marketing and Development for First Genetic Trust, Inc. which developed software for large-scale collaborative genetic research and personalized medicine. During a 16-year career at IBM, he co-led the corporate strategy team that guided IBM’s formation of its Life Sciences industry organization and its first product, DiscoveryLink database integration software, in 2000. Mr. Wholley holds an M.A. from Rutgers University and a Certificate in Business Administration from the Stern School of Business at New York University.
Contact information: dwholley [at] fnih [dot] org, (301) 594-6343
How We Make a Difference |

The premier institution in the world for fundamental science, The National Institutes of Health (NIH) places equal emphasis on translational medicine—translating discoveries in the laboratory into real patient benefits—such as improved diagnoses, therapies and cures.
The Foundation for NIH is instrumental to making this happen, through wide-ranging partnerships throughout the world.
FNIH in the News |






